Journal
JOURNAL OF IMMUNOLOGY
Volume 192, Issue 5, Pages 2210-2218Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1302145
Keywords
-
Categories
Funding
- Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases
- Japan Society for Promotion of Science
- Japanese Ministry of Education, Science and Culture
- Kaibara Morikazu Medical Science Promotion Foundation
- Takeda Science Foundation
- Grants for Excellent Graduate Schools, MEXT, Japan
Ask authors/readers for more resources
gamma delta T cells develop at the double-negative (DN) 2 and DN3 stages and acquire functions to produce IL-17 and IFN-gamma in fetal thymus. However, the relationship between differentiation stages and their functions was unclear. In this study, we found that, although IFN-gamma-producing and IL-17-producing gamma delta T cells developed from DN2 cells, only IFN-gamma-producing gamma delta T cells developed from DN3 cells, indicating the direct generation of IL-17-producing gamma delta T cells from the DN2 stage, not through the DN3 stage. Single-cell analysis revealed that DN2 cells contained heterogeneous gamma delta T cell precursors with or without an ability to develop IL-17 producers. Inactivation of B cell leukemia/lymphoma 11b, a zinc finger transcription factor responsible for transition from early to late stages of DN2 cells, completely abrogated the development of IL-17-producing gamma delta T cells, although a unique subset of IFN-gamma-producing gamma delta T cells expressing a high level of promyelocytic leukemia zinc finger was able to develop. Thus, our results reveal that gamma delta T cells are functionally differentiated to IFN-gamma and IL-17 producers at different developmental stages in fetal thymus.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available